找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Java in the 14th Century; A Study in Cultural Theodore G. Th. Pigeaud Book 1960 Springer Science+Business Media Dordrecht 1960 Java.cultur

[复制链接]
查看: 18521|回复: 55
发表于 2025-3-21 18:45:38 | 显示全部楼层 |阅读模式
书目名称Java in the 14th Century
副标题A Study in Cultural
编辑Theodore G. Th. Pigeaud
视频video
丛书名称Koninklijk Instituut voor Taal-, en Volkenkunde
图书封面Titlebook: Java in the 14th Century; A Study in Cultural  Theodore G. Th. Pigeaud Book 1960 Springer Science+Business Media Dordrecht 1960 Java.cultur
描述The Dutch Nagara-Kertagama translation on which Professor Kern worked, at intervals, during eleven years, deserves our utmost admir­ ation and respect. It is the last important piece of work he finished before his death. It has enriched in an extraordinarily high degree our knowledge of the history and antiquities of the Majapahit period. Moreover, its dignified and courtly style established the reputation of Old Javanese letters as a literature of considerable interest. The con­ tents of the Nagara-Kertiigama, as interpreted by Professor Kern, gave 14th century Majapahit a nimbus, making it appear to the uncritical public as a most powerful and highly cultured Empire, organized on 18th or 19th century West-European lines. The notes of Krom, Poerbatjaraka and others do not contain com­ plete translations of the texts. These scholars made valuable contribu­ tions to a better understanding of several passages. They did not make it easy for the general reader to consult their notes, though. Professor Kern‘s appreciation of the contents of the Nagara-Kertagama remained fundamentally unshaken. Up to the present time Professor Kern‘s Nagara-Kertagama trans­ lation has been generally used
出版日期Book 1960
关键词Java; cultural history; death; organ; organization; religious communities; temple; translation; writing
版次1
doihttps://doi.org/10.1007/978-94-011-8772-5
isbn_softcover978-94-011-8149-5
isbn_ebook978-94-011-8772-5
copyrightSpringer Science+Business Media Dordrecht 1960
The information of publication is updating

书目名称Java in the 14th Century影响因子(影响力)




书目名称Java in the 14th Century影响因子(影响力)学科排名




书目名称Java in the 14th Century网络公开度




书目名称Java in the 14th Century网络公开度学科排名




书目名称Java in the 14th Century被引频次




书目名称Java in the 14th Century被引频次学科排名




书目名称Java in the 14th Century年度引用




书目名称Java in the 14th Century年度引用学科排名




书目名称Java in the 14th Century读者反馈




书目名称Java in the 14th Century读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:16:07 | 显示全部楼层
发表于 2025-3-22 03:26:19 | 显示全部楼层
发表于 2025-3-22 05:03:24 | 显示全部楼层
发表于 2025-3-22 08:49:42 | 显示全部楼层
Theodore G. Th. Pigeaud Ph. D.sed CNN as feature extractor by removing the last classification layers and we have passed the features to Random Forest; and the last one is by using transfer learning–Fine-Tuning–pre-trained CNN “DenseNet201” as classifier. Finally, we have evaluated our models using three metrics: accuracy, preci
发表于 2025-3-22 14:51:21 | 显示全部楼层
发表于 2025-3-22 18:44:25 | 显示全部楼层
Theodore G. Th. Pigeaud Ph. D.ving the negative regulation over T cells [6–8]. Recent FDA approval of CAR-T therapy (chimeric antigen receptor T-cell therapy by genetically engineered T cells for antigen‐specific tumor therapy) for B‐cell and non‐Hodgkin lymphoma therapy is also emerging news in the immunotherapy field [9, 10].
发表于 2025-3-22 22:36:05 | 显示全部楼层
Theodore G. Th. Pigeaud Ph. D.ving the negative regulation over T cells [6–8]. Recent FDA approval of CAR-T therapy (chimeric antigen receptor T-cell therapy by genetically engineered T cells for antigen‐specific tumor therapy) for B‐cell and non‐Hodgkin lymphoma therapy is also emerging news in the immunotherapy field [9, 10].
发表于 2025-3-23 02:20:50 | 显示全部楼层
Theodore G. Th. Pigeaud Ph. D.ving the negative regulation over T cells [6–8]. Recent FDA approval of CAR-T therapy (chimeric antigen receptor T-cell therapy by genetically engineered T cells for antigen‐specific tumor therapy) for B‐cell and non‐Hodgkin lymphoma therapy is also emerging news in the immunotherapy field [9, 10].
发表于 2025-3-23 07:56:40 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-3 05:43
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表